HER2-mRNA-LNP vaccine

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameHER2-mRNA-LNP vaccine
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe Fourth Hospital of Hebei Medical University (Hebei Cancer Hospital)
China Registration ClassN/A

Develop Information

Active CompaniesThe Fourth Hospital of Hebei Medical University (Hebei Cancer Hospital)
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A